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Abstract
The cytoplasmic polyadenylation element binding protein CPEB1 (CPEB) regulates germ cell development, synaptic
plasticity, and cellular senescence. A microarray analysis of mRNAs regulated by CPEB unexpectedly showed that several
encoded proteins are involved in insulin signaling. An investigation of Cpeb1 knockout mice revealed that the expression of
two particular negative regulators of insulin action, PTEN and Stat3, were aberrantly increased. Insulin signaling to Akt was
attenuated in livers of CPEB–deficient mice, suggesting that they might be defective in regulating glucose homeostasis.
Indeed, when the Cpeb1 knockout mice were fed a high-fat diet, their livers became insulin-resistant. Analysis of HepG2
cells, a human liver cell line, depleted of CPEB demonstrated that this protein directly regulates the translation of PTEN and
Stat3 mRNAs. Our results show that CPEB regulated translation is a key process involved in insulin signaling.
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Introduction
The maintenance of glucose homeostasis requires that organ-
isms respond to changing environmental conditions by balancing
pancreatic insulin secretion with the ability of tissues, particularly
liver, muscle, and fat, to respond to hormone-induced signaling by
importing or secreting glucose [1,2]. Obesity and other insults that
promote diabetes do so by causing inflammation and insulin
resistance, which is characterized by the inability of tissues to
transduce insulin/insulin receptor interactions into elevated
glucose uptake in muscle and adipose tissue and/or efficient
insulin-mediated suppression of gluconeogenesis in liver. In
peripheral tissues such as those noted above, insulin association
with the insulin receptor (InsR; NM_010568.2) induces insulin
receptor substrates (IRS1/2; NM_010570/NM_001081212.1)
tyrosine phosphorylation, which through activated PI3-kinase,
promotes the phosphorylation of phosphatidylinositol 4,5-bispho-
sphate (PIP2) to yield phosphatidylinositol (3,4,5)-trisphosphate
(PIP3). This process is inhibited by the phosphatase PTEN
(NM_008960.2). PIP3 promotes the membrane localization of
PDK1 (NM_008960.2) and Akt1 (NM_011062.4), where PDK1
and PDK2 phosphorylate Akt1, resulting in glucose uptake and
metabolism. In addition to PTEN, a number of factors can
regulate these events. For example, inflammatory pathways have a
profound negative impact on insulin signaling; in one instance,
Stat3 activation induces Socs3 transcription, which in turn
indirectly represses InsR and IRS1/2 activities [3,4].
CPEB (NM_007755.4) is an mRNA binding protein that controls
cytoplasmic polyadenylation-induced translation by interacting with
the 39 UTR cis-acting cytoplasmic polyadenylation element (CPE)
and three regulatory proteins including Gld2 (NM_001094423.1), a
poly(A) polymerase; PARN (NM_001087674.1), a deadenylating
enzyme, andMaskin (NM_001088495.1), which also associates with
eIF4E (NM_001090548.1), the cap-binding factor [5]. Initial
CPEB-repression occurs because Maskin binding to eIF4E
precludes the eIF4E-eIF4G interaction that is necessary to recruit
the 40S ribosomal unit to the 59 end of the mRNA. Because Maskin
is tethered to CPE, only CPE-containing RNAs are repressed.
CPEB-induced stimulated (i.e., deprepressed) translation is initiated
when CPEB is phosphorylated on S174 or T171 (species-
dependent), which expels PARN from the ribonucleoprotein
complex. This event allows Gld2 to polyadenylate the RNA by
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default. The newly elongated poly(A) tail is then bound by poly(A)
binding protein (PABP), which also binds eIF4G; the PABP/eIF4G
complex displacesMaskin from eIF4E, allowing for formation of the
initiation complex on the 59 cap structure.
By regulating mRNA-specific translation, CPEB profoundly
influences gametogenesis and early development [6,7,8], neuronal
synaptic plasticity [9,10], and cell-cycle progression [11]. CPEB
also regulates translation during cellular senescence; fibroblasts
derived from Cpeb1 knockout (KO) mice do not senesce as do wild
type (WT) cells, but are immortal [12]. Similarly, human cells
depleted of CPEB bypass senescence and have a three-fold
extended lifespan [13]. In the mouse cells, aberrant over-
expression of myc (NM_001177353.1) mRNA is at least one
event that mediates the senescence response [12], while in human
cells, reduced p53 (NM_000546.4) mRNA translation accounts for
the senescence bypass [13].
To identify additional mRNAs that are translationally regulated
by CPEB during senescence, we used sucrose density gradient
centrifugation to prepare polysomes from WT and Cpeb1 KO
mouse embryo fibroblasts (MEFs) followed by microarray analysis.
Unexpectedly, several mRNAs encoding insulin-signaling mole-
cules (see below) were found to be excessively polysomal in the KO
versus WT MEFs. Consequently, we investigated the involvement
of CPEB in insulin signaling and glucose homeostasis. In Cpeb1
KO liver, muscle, and fat, there was a dramatic and widespread
mis-expression of insulin-signaling proteins. Increased expression
of two major negative regulators of insulin signaling, PTEN and
Stat3 (NM_213659.2), was associated with reduced Akt phos-
phorylation in both Cpeb1 KO liver and in CPEB-depleted HepG2
human liver cells. When fed on a high fat diet, WT and Cpeb1 KO
mice were both obese, but only the KO animals displayed liver
insulin resistance. These and other data demonstrate that CPEB
control of PTEN and Stat3 mRNA translation is essential for liver
insulin signaling and glucose homeostasis.
Results
CPEB deficiency results in widespread impairment of
insulin signaling
MEFs derived from CPEB knockout mice do not senesce as do
WT MEFs, but instead are immortal [12]. Similarly, primary
human skin fibroblasts in which CPEB is depleted also bypass
senescence [13,31]. Senescence bypass is caused by altered
translation of myc and p53 mRNAs, which are directly bound
by CPEB. We suspected that additional mRNAs whose translation
is controlled by CPEB would also be involved in senescence; to
identify them, we performed microarray analysis of mRNAs
associated with polysomes in wild type (WT) and Cpeb1 KO MEFs
(Figure 1; Table S1). Several of these mistranslated mRNAs
control p53-related processes, which given the importance of p53
in senescence, was not unexpected result. However, we also
noticed that several aberrantly translated mRNAs encoded
proteins involved in insulin signaling, which surprisingly suggested
that this signal transduction pathway and perhaps glucose
metabolism might be compromised in Cpeb1 KO mice. Conse-
quently, we probed western blots for insulin signaling proteins
derived from WT and Cpeb1 KO liver, muscle, and fat. Figure 2A
shows dramatic and widespread mis-expression of many insulin-
signaling molecules (reference 8 shows knockout of CPEB gene;
Figure S1A shows a western blot of CPEB in WT and KO liver).
Critical proteins such as PTEN, Stat3, and Socs3 (NM_007707.3)
were all elevated in KO liver, muscle, and fat, usually by 2–3 fold.
With the exception of Socs3 and IRS2 mRNAs, the levels for the
mRNAs encoding these proteins were rarely changed in liver.
(Figure 2B). One central insulin-signaling molecule is Akt, which is
phosphorylated on S473 and T308 following insulin stimulation;
the phosphorylation of these residues is necessary to maintain
glucose homeostasis. In fasting WT mice injected with insulin,
there was a dramatic increase in liver phospho-S473 and phospho-
T308 Akt, but not total Akt, as expected. In Cpeb1 KO mice,
however, there was virtually no phosphorylation of Akt irrespec-
tive of insulin treatment (Figure 3A). In both fat (Figure 3B) and
muscle (Figure 3C), AKT was phosphorylated in the KO in
response to insulin, indicating that liver is uniquely affected by the
lack of CPEB. In the KO liver, phospho-GSK-3b is elevated upon
insulin stimulation, albeit not as much as WT (Figure 3D).
Phospho-FOXO-1 was also somewhat elevated in KO liver in
response to insulin, but significantly less than in WT. In muscle
and fat, these and other signaling molecules were largely unaltered
by insulin treatment (Figure S1B). It is curious why these two
tissues, but not liver, had normal levels of signaling molecules
following application of insulin. Perhaps tissue-specific regulatory
molecules such as kinases or miRNAs ameliorate or compensate
for the lack of CPEB. Taken together, these data indicate that
insulin signaling, particularly in the liver, is compromised by
CPEB depletion.
The data in Figure 2 suggest that the absence of CPEB may
may affect the translation of mRNAs that encode insulin-signaling
proteins. To assess this possibility, we employed HepG2 human
hepatocarcinoma cells that were infected with lentivirus expressing
a control shRNA or one against CPEB (shCPEB). The knockdown
was confirmed by RT-PCR of CPEB RNA and by down-
regulation of ectopically expressed FLAG-CPEB (Figure 4A, 4B).
As noted above, Akt phosphorylation was strongly reduced in
Cpeb1 KO liver following insulin injection. Depletion of CPEB
from HepG2 cells also resulted in reduced insulin-stimulated Akt
S473 and T308 phosphorylation (Figure 4C), although not to the
extent observed in Cpeb1 KO liver. Ectopic expression of CPEB
following shRNA-mediated depletion mostly restored Akt S473
phosphorylation (Figure 4D; phospho-T308 was not examined),
which further demonstrates the importance of CPEB for Akt
activation. Thus, insulin-treated HepG2 cells depleted of CPEB
mimic insulin-injected Cpeb1 KO mouse liver. Finally, we
expressed FLAG-tagged CPEB and CPEBDZF, which lack two
zinc fingers that are necessary for RNA binding, in HepG2 cells
followed by FLAG immunoprecipitation (Figure S1C) and RT-
PCR to detect putative target mRNAs. Figure 4E shows that of
seven CPE-containing RNAs tested, those encoding Stat3, PTEN,
PDK1, IRS1, and Pik3C (subunit of PI3-kinase) were co-
Author Summary
One major hallmark of diabetes is insulin resistance in
peripheral tissues that is controlled at the posttranslational
level. For example, insulin activates a kinase cascade that
leads to the phosphorylation of Akt, a centrally important
molecule that regulates glucose metabolism. In this study,
we define a translational regulatory pathway that mediates
insulin action in the liver. The Cytoplasmic Polyadenylation
Binding Protein (CPEB) interacts with mRNA to control
translation; knockout mice that lack CPEB exhibit high-fat-
diet-induced liver insulin resistance and do so by having
aberrant expression of major insulin signaling molecules,
in particular PTEN 3 and Stat3. Our data further suggest
that CPEB modulates, in a manner similar to a rheostat,
functionally related mRNAs that encode proteins involved
in insulin signaling.
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immunoprecipitated with CPEB but not CPEBDZF, suggesting
that they might be direct targets of CPEB regulation.
CPEB represses the translation of Stat3 and PTEN mRNAs
Because of their central role in insulin signaling and their robust
change in KO liver, we focused on PTEN and Stat3 as possible
direct targets of CPEB regulation. The 39 UTRs of both RNAs
contain conserved CPEs (Figure 5A, 5B), indicating that CPEB
association with these transcripts as demonstrated in Figure 4E is
probably direct. Depletion of CPEB from HepG2 cells resulted in
elevated amounts of Stat3 and PTEN when examined by western
blotting (Figure 5C, 5D; Figure 5E and 5F show that CPEB
depletion had no effect on Stat3 or PTEN mRNA levels).
However, because western blots reflect steady state protein levels
and not necessarily protein synthesis, control and CPEB-depleted
cells were pulse-labeled with 35S-methionine for 15 minutes,
followed by Stat3 and PTEN immunoprecipitation and SDS-
PAGE analysis. Figure 5G and 5H show that de novo labeling of
Stat3 and PTEN mimics the western analysis of these proteins, and
indicates that their mRNAs are under direct translational control
by CPEB. As a control, Figure 5G shows that 35S-methionine
labeled tubulin was unaffected by CPEB depletion. To buttress the
conclusion that CPEB regulates Stat3 and PTEN at the
translational level, the 39 UTRs of these mRNAs, containing or
lacking the CPEs, were appended to firefly luciferase RNA
(Figure 5I). These reporters, which together with Renilla luciferase
RNA that served as an internal reference standard, were
electroporated into control or CPEB-depleted HepG2 cells. The
depletion of CPEB resulted in ,50% increase of firefly luciferase
RNA translation when the reporter contained either the Stat3 or
PTEN 39 UTRs. Moreover, nearly identical expression levels were
observed when the CPEs were mutated, irrespective of whether
the cells contained CPEB (Figure 5J, 5K, upper graph). There was
no detectable difference in the stabilities of any of the
electroporated RNAs (Figure 5J, 5K, lower panel). Finally, the
polysome sedimentation profiles in Figure S1C show that CPEB
represses translation of Stat3 and PTEN mRNAs, but not IRS1 or
PDK1 mRNAs. Taken together, the data in Figure 5 as well as in
Figure S1C demonstrate that CPEB acts directly on Stat3 and
PTEN mRNAs to repress their translation.
Figure 1. Analysis of polysome sucrose gradients reveals CPEB control of insulin signaling. Extracts prepared from WT and CPEB KO
MEFS were centrifuged through sucrose gradients; the fractions containing polysomes were pooled, the RNA extracted, and used to probe
microarrays. A functional annotation analysis reveals changes in the translation of a number of mRNAs involved in insulin signaling.
doi:10.1371/journal.pgen.1002457.g001
CPEB Deficiency Induces Hepatic Insulin Resistance
PLoS Genetics | www.plosgenetics.org 3 January 2012 | Volume 8 | Issue 1 | e1002457
Cpeb1 knockout mice are insulin-resistant
Although the data in Figure 2 demonstrate that the Cpeb1 KO
mice have substantial alterations in the levels of insulin signaling
proteins, the animals are normal in size and mass. However, because
neither of these observations speaks directly to possible changes in
glucose metabolism, we subjected the animals to a glucose tolerance
test (GTT), which measures glucose clearance from the blood. In this
regard, the WT and KO animals were indistinguishable (Figure 6A).
On the other hand, serum insulin levels measured during the GTT
were significantly higher in the KO mice, which would indicate
insulin resistance. To examine this possibility, we performed an
insulin tolerance test (ITT). After a 5 hour fast, animals were injected
with insulin, which was followed by serum glucose determination 0–
60 minutes later. Compared to WT, the KO animals had
Figure 2. Dramatic and widespread changes in insulin signaling molecules in CPEB knockout mice. (A) Western blot analysis and
quantification of IRS1, IRS2, PTEN, PDK1, phospho-Stat3 (S727), total Stat3, Socs3, and tubulin as a loading control from WT and CPEB knockout liver,
fat, and muscle. (B) Quantitative RT-PCR analysis of mRNAs encoding IRS1, IRS2, PTEN, PDK1, Stat3, and Socs3 mRNAs from WT and Cpeb1 KO liver.
Data are represented as mean +/2 SEM. At least 3 animals per group were used for the experiment. Asterisks refer to statistical significance at the
p,0.05 (*) or p,0.01 (**) levels (Student’s t test).
doi:10.1371/journal.pgen.1002457.g002
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significantly higher levels of glucose (Figure 6A); these data, together
with those showing that insulin-injected KO animals have very low
levels of phospho-Akt, indicate that the absence of CPEB induces
insulin resistance. We also examined insulin secretion from isolated
pancreatic islets from WT and CPEB KO mice; when challenged
with glucose, we detected no statistical difference between the two
groups of animals (data not shown).
We measured the levels of a number of cytokines and hormones
and found that IL6 (NM_031168.1) was elevated by ,5 fold in
KO mouse serum (Figure S2A). Increased amounts of this cytokine
often correlate with insulin resistance and diabetes [14]. This
observation supports the notion that the KO animals have an
activated inflammatory Jak-Stat signaling pathway, which is
further indicated by enhanced Stat3 phosphorylation and Socs3
Figure 3. CPEB mediates insulin signaling in the liver. (A) Western blot and quantification of total and phospho-Akt (serine 473 and threonine
308) from liver of WT and Cpeb1 KO mice, some of which were injected with insulin. The pAkt (Ser473) and pAkt (Thr308) data were analyzed with
ANOVA with (p,0.05, *; p,0.01, **). Data are represented as mean +/2 SEM. In this and all panels, at least 3 animals per group were used for the
experiment. (B,C) Phospho-Akt (threonine 308) in CPEB KO fat and muscle, respectively. Analysis as in panel A. (D) Examination of insulin signaling
molecules in WT and CPEB KO liver. Analysis as in panel A.
doi:10.1371/journal.pgen.1002457.g003
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expression in the liver (Figure 2). Because inflammation can
exacerbate insulin resistance, CPEB might control the expression
of a number of molecules in several tissues to ensure that proper
glucose levels are maintained.
To determine whether the insulin resistance can be magnified
by metabolic insult, WT and Cpeb1 KO mice were fed a high fat
diet (HFD) for 7 weeks, which elicited obesity in both groups of
animals (whole body mass); there was also no difference in fat or
lean mass between the genotypes (Figure 6B). To investigate
organ-specific effects of CPEB deletion on insulin action, we
performed a 2-hr hyperinsulinemic-euglycemic clamp in conscious
WT and KO mice. The steady-state glucose infusion rate to
maintain euglycemia during clamps was reduced by ,50% in the
KO animals, although this was not statistically significant
(p = 0.197). In addition, insulin-stimulated whole body glucose
turnover, glycolysis, and glycogen plus lipid synthesis were
unaffected in the Cpeb1 KO mice (Figure 6C). However, hepatic
insulin action, expressed as insulin-mediated percent suppression
of hepatic glucose production (HGP), was significantly compro-
mised in the Cpeb1 KO mice (Figure 6C). The cause of this
decrease in basal HGP is not clear, but because fasting levels of
glucose and insulin are not affected by genotype, it may indicate,
for example, aberrant gluconeogenesis. Finally, analysis of WT
and KO liver following the euglycemic clamp demonstrates that
although Akt was strongly phosphorylated in WT animals
following insulin administration as expected, this was not the case
with the Cpeb1 KO liver (Figure 6D). We also measured fasting
glucose and insulin levels in WT and KO mice fed normal chow
and a high fat diet (Figure S2B). As expected, glucose levels for
both genotypes increased on a high fat diet. Relative to WT,
insulin levels in the CPEB KO animals were elevated on normal
chow, but did not change further on a high fat diet. These data
demonstrate that Cpeb1 KO mice fed a HFD developed defects in
insulin signaling and hepatic insulin resistance.
Discussion
Although the inflammatory response is known to be regulated
by 39UTR binding proteins that affect translation and stability
[15], there is a paucity of information regarding such proteins in
insulin resistance or diabetes. Our data indicate that CPEB
integrates the expression of several mRNAs involved in insulin
signaling. Coordinate posttranscriptional regulation of factors in a
given signal transduction pathway, or coordinate regulation of
multiple processing steps (e.g., splicing, export, localization, and
translation) of a given RNA are two examples of a ribonome
regulation (also sometimes referred to as a regulon) [16,17]; see
also [18]). Post-transcriptional regulons mediate the inflammatory
Figure 4. CPEB depletion in HepG2 cells results in aberrant insulin signaling. (A) HepG2 cells were infected with lentiviruses expressing a
control shRNA or one directed against CPEB; extracted RNA was then assessed for CPEB RNA, and tubulin as a control. (B) HepG2 cells were co-
infected with the lentiviruses noted above as well as a retrovirus expressed FLAG-CPEB; western blots were probed for the FLAG epitope and tubulin.
(C) HepG2 cells infected with lentivirus expressing control or CPEB shRNA were treated with insulin and western blotted for phospho (S473 and T308)
and total Akt. The pAkt (Ser473) and pAkt (Thr308) data were analyzed with ANOVA (p,0.05, *). All experiments were performed 3 times. (D) HepG2
cells co-infected with the viruses noted above were western blotted for phospho (S473) and total Akt. The pAkt (Ser473) data was analyzed by
ANOVA (p,0.05). (E) HepG2 cells infected with virus expressing FLAG-CPEB or FLAG-CPEBDZF, which lacks two zinc fingers and cannot bind RNA,
followed by FLAG co- immunoprecipitation and analysis of Stat3, PTEN, PDK1, IRS1, IRS2, and Socs3 RNAs by quasi-quantitative RT-PCR. Input
represents 10% of total. At least 3 animals per group were used for the experiment.
doi:10.1371/journal.pgen.1002457.g004
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Figure 5. CPEB controls the synthesis of Stat3 and PTEN. (A and B) 39 UTR sequences of Stat3 and PTEN from human, mouse and cow. The
nucleotides in bold represent putative CPEs. (C and D) Western blots of Stat3 and PTEN following CPEB depletion in HepG2 cells. In panels C-H,
tubulin served as a negative or input control. (E and F) Quasi-quantitative RT-PCR for Stat3 and PTEN RNAs following CPEB depletion. (G and H)
CPEB Deficiency Induces Hepatic Insulin Resistance
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response [15], and neurologic disease [19,20]; they may do so by,
for example, controlling RNA decay [15], among other events. In
addition to networks mediated by RNA binding proteins, others
are controlled by miRNAs. For example, miR143/145
(MI0000257/MI0000169) control the expression of several
mRNAs to ensure proper smooth muscle development [21,22].
Similarly, miR126 (MI0000153) acts on a number of RNAs to
mediate angiogenesis [23]. Finally, RNA binding proteins and
miRNAs can act together or oppose one another to control the
expression of multiple RNAs that define complex cellular states
such as neuronal differentiation or epithelial to mesenchyme
transition [24]. In the examples noted above, however, no single
protein or miRNA controls mRNA expression in a particular
signal transduction pathway, rather, a given physiology is
modulated at multiple levels (e.g., by controlling multiple signaling
events) by certain proteins or miRNAs. In contrast, results
reported here show that CPEB regulates the expression of several
components of a single signal transduction pathway. Consequent-
ly, we propose that an insulin-signaling regulon is controlled at
least in part by CPEB. It is remarkable that of the 25 components
noted in Figure 7 that influence insulin signaling, mRNAs
encoding 21 of them contain CPEs conserved across species.
HepG2 cells depleted of CPEB were pulse labeled with 35S-methionine for 15 min followed by Stat3, PTEN and tubulin (as a control)
immunoprecipitation and SDS-PAGE analysis. These same proteins were also analyzed by western blots. (I) Representation of Renilla and firefly
luciferase RNAs that were electroporated into HepG2 cells. Renilla luciferase RNA, which contained an irrelevant 39 UTR, served as a normalization
control. Firefly luciferase contained the Stat3 or PTEN 39 UTRs as noted in panels A and B; in some cases, the CPEs in these 39 UTRs were mutated. (J
and K) The firefly and Renilla RNAs noted above were electroporated into HepG2 cells, some of which were depleted of CPEB. Firefly luciferase was
normalized to the Renilla luciferase transfection control; luciferase activity derived from all RNAs was then made relative to the control shRNA. The
Stat3 and PTEN data were analyzed with ANOVA; p values were 0.009 and 0.005, respectively. The asterisk refers to statistical significance (p,0.05).
Data are represented as mean +/2 SEM. The firefly and Renilla luciferase RNAs were also analyzed for relative stability by quasi-quantitative RT-PCR;
all the RNAs had similar stabilities. At least 3 animals were used for each experiment.
doi:10.1371/journal.pgen.1002457.g005
Figure 6. Cpeb1 KO mice are insulin-resistant. (A) WT and KO mice were fed a normal chow diet and then examined for glucose tolerance test,
serum insulin levels, and insulin tolerance. ANOVA values are as indicated in the figure. (B) Measurements for lean mass, fat mass, and total body mass
of WT and Cpeb1 KO mice fed a high fat diet. (C) Animals fed a high fat diet were subjected to euglycemic clamp analysis that determined glucose
infusion rate (GIR), glucose turnover, whole body glycolysis, glycogen synthesis, hepatic glucose production (HGP), and liver insulin action (the ratio
of basal to clamped HGP). The HGP data were analyzed with ANOVA with a value of 0.006. The asterisks in this panel as well as panel D refer to
statistical significance (p,0.05). (D) Following the euglycemic clamp, liver proteins from WT and KO animals were probed on western blots for total
and phospho-Akt (S473 and T308). The pAkt (Ser473) and pAkt (Thr308) data were analyzed with ANOVA with suggestive values of 0.01999 and
0.08335 values respectively. Data are represented as mean +/2 SEM. At least 3 animals per group were used for the Western blots and at least 6
animals per group were used to measure the physiological parameters.
doi:10.1371/journal.pgen.1002457.g006
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While not all of these mRNAs are likely to be directly regulated by
CPEB (indeed, two of them, IRS2 and Socs3, do not co-IP with
CPEB), the preponderance of CPEs suggests that CPEB influences
the expression of many of them.
Although CPEB was first described as an mRNA stimulatory
factor by way of inducing poly(A) tail length [25,26], recent
evidence shows that it can also repress translation [12].
Presumably, the factors with which CPEB associates in any given
cell determines whether it will stimulate or repress translation. In
the liver, at least for the messages we examined, CPEB seems to
repress translation; when it is not present in KO mice, the
synthesis of certain proteins such as PTEN and Stat3 are elevated.
However, it should be borne in mind that translational repression
is often reversible. It is possible that under some conditions, CPEB
would be released from the RNA, which would elicit enhanced
translation. Irrespective of how CPEB regulates translation, why
would the insulin signaling cascade be controlled by this protein?
We propose that CPEB acts as a rheostat to modulate the levels of
insulin signaling proteins in response to particular environmental
cues. For example, CPEB activity might be turned up or down in
response to a high fat diet, and thereby modulate the degree of
insulin sensitivity. If such is the case, then CPEB performance
could play a central role in glucose homeostasis.
Materials and Methods
Animals
Male C57BL/6 Cpeb1 KO mice (12 weeks old) (Tay and
Richter, 2001) were fed normal chow diet or a high fat diet (HFD;
55% fat by calories, Harlan Teklad) for 7 weeks. Mostly littermates
were used for all experiments, in some cases mice with +/21 week
of birth date were used.
Ethics statement
The animals, which were housed in the UMass Medical School
animal facility, were used according to guidelines approved the
Institutional Animal Care and Use Committee and fully comply
with all applicable Federal and State requirements.
Reagents and antibodies
Mouse CPEB (WT and DZF) was cloned into a FLAG
containing vector (Nagaoka and Richter, submitted). PTEN and
Stat3 39 UTRs (nucleotides 1–90 and 1–195, respectively) were
cloned into EcoRI-XhoI sites of pcDNA3.1+ vector containing
firefly luciferase. In some cases, the CPEs were mutated to C or G
in place of T. Renilla luciferase (pRL-TK; Promega) was used as a
control vector in the luciferase experiments. Antibodies to PTEN
(Cell Signaling), Akt1, and pAkt473 (Cell Signaling) were a
generous gift from M. Sherman. Antibodies to Socs3 (Cell
Signaling) and pAkt308 (Cell Signaling) were a generous gift from
R. Davis. IRS2 and IR antibody was a generous gift from M.
White. Antibodies to PDK1 (Genetex), IRS1 (Upstate), tubulin
(Sigma). were purchased from the indicated commercial sources.
Antibodies to Stat3, pStat3, GSK-3, pGSK-3, FOXO, pFOXO,
pIRS-1 were obtained from Cell Signaling. See Protocol S1 for
additional information.
Biochemical assays and cell culture
Mouse tissues (liver, fat- white adipose tissue only, muscle) and
HepG2 cells were lysed in buffer (50 mM Tris-HCl (pH 7.4),
0.25 M NaCl, 1 mM MgCl2, 0.1 mM CaCl2, 1% NP-40, 0.5%
deoxycholate, 0.1% SDS) with protease inhibitor (Complete,
Roche) and phosphatase inhibitors (vanadate and fluoride, NEB).
Western blots were performed with these samples using ECL
(Perkin-Elmer), or Femto-ECL (Pierce) detection systems. RNP co-
immunoprecipitation using Dynabeads (Invitrogen) was performed
in the same buffer with RNase inhibitor (RNAseOut, Invitrogen)
and antibody against the FLAG epitope (Sigma). The RNA was
extracted from the final precipitate (or from total RNA) with
Trizol (Invitrogen) and subjected to quantitative RT-PCR
(Quantitect RT kit, Qiagen).
Firefly luciferase RNAs appended with Stat3 or PTEN 39 UTRs
containing or lacking CPEs were synthesized in vitro with T7
RNA polymerase (mMessage Machine kit; Ambion). Control
Renilla luciferase RNA containing an irrelevant 39 UTR was
polyadenylated with E. coli polyA polymerase (NEB). Each of the
firefly luciferase RNAs together with the Renilla luciferase RNA
was used to transfect (with lipofectamine 2000) or nucleofect (with
Amaxa nucleofector) HepG2 human hepatocarcinoma cells
(ATCC #CRL-10741) that were grown to 50% confluency. Some
of these cells were also infected with lentivirus harboring control or
CPEB shRNA as described by Udagawa et al. (submitted).
Infectivity was monitored by GFP, which was encoded by the
virus. After infection, fresh DMEM with 10% FBS was added.
Luciferase activity was determined 12 hr after cell transduction
with a Dual-Luciferase Reporter Assay System (Promega) and
normalized to the Renilla control. Luminescence was detected with
a SAFIRE multimode microplate reader (Tecan).
Glucose and insulin tolerance tests and plasma serum
analysis
Glucose tolerance (GTT) and insulin tolerance tests (ITT) were
performed using methods described previously [27]. Serum insulin
concentrations during the GTT were determined using an insulin
ELISA (Crystal Chem). Blood glucose was measured using an
Ascensia Breeze 2 glucometer (Bayer). Statistical analysis was
Figure 7. Proposed model for CPEB-dependent regulation of the insulin-signaling ribonome regulation. The dark gray boxes refer to
mRNAs that contain conserved CPEs and can potentially be regulated by CPEB. The light gray boxes refer to mRNAs that contain conserved CPEs but
because they are not co-immunoprecipitated with CPEB, are probably not regulated by this protein in the current settings. The striped boxes refer to
mRNAs that contain conserved CPEs and are regulated by CPEB. Insulin mRNA does not contain a CPE.
doi:10.1371/journal.pgen.1002457.g007
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performed by ANOVA. Serum adipokines, cytokines, and insulin
were measured by ELISA using a Luminex 200 luminometer
(Millipore).
Hyperinsulinemic-euglycemic clamp
Hyperinsulinemic-euglycemic clamps were performed at the
UMass Mouse Phenotyping Center. Mice were fed normal chow
or a HFD for 7 weeks. Whole body fat and lean mass were non-
invasively measured using proton magnetic resonance spectrosco-
py (1H-MRS) (Echo Medical Systems). Following an overnight
fast, a 2 hr hyperinsulinemic-euglycemic clamp was performed
with a primed and continuous infusion of human insulin
(150 mU/kg body; 2.5 mU/kg/min; Humulin; Eli Lilly), and
20% glucose was infused to maintain euglycemia (Kim et al.,
2004). Whole body glucose turnover and glucose uptake in
individual organs were determined by infusion of 3H-glucose and a
bolus injection of 14C-2-deoxyglucose during clamps. Following
the clamp, tissues were harvested for biochemical analysis [28].
Microarray analysis
Fibroblasts (MEFs) isolated from WT and CPEB KO mice
E12.5–E14.5 embryos (MEFs) were cultured in Dulbecco’s
Modified Eagle’s Medium with 10% fetal bovine serum according
to a 3T3 protocol [12]. The cells were harvested in the presence of
100 mg/ml cycloheximide (Sigma) and subjected to polysome
fractionation [30]. The lysate was layered onto a continuous
sucrose gradient (15%–50%) and centrifuged for 2 h at 40 000
RPM in a SW41 rotor. The RNA was isolated from polysomal
fractions, pooled, and subjected to microarray analysis by UMass
Medical School Genomics Core facility with Affymetrix GeneChip
Mouse Genome 430A 2.0 array. The gradients were performed
with biologic triplicates. The data were analyzed with DAVID
Bioinformatics Resources 6.7, Panther pathway annotation
[29,32], and deposited at http://www.ncbi.nlm.nih.gov/geo/
(series number GSE28106).
Statistical analyses
Results are presented as mean 6 SEM. The error bars in all
figures are SEM. A p,0.05 was considered significant. We used
two-way ANOVA to assess significance (p,0.05). We further
performed a pair-wise comparison (t-test) between groups.
Supporting Information
Figure S1 CPEB mediates liver insulin signaling. (A) Western
blot of CPEB in WT and KO liver. (B) Western blots of insulin
signaling molecules, and tubulin as a control, in muscle and fat
derived from untreated and insulin treated WT and CPEB KO
mice. (C) HepG2 cells infected with virus expressing FLAG-CPEB
or FLAG-CPEBDZF, which lacks two zinc fingers and cannot
bind RNA, followed by FLAG coimmunoprecipitation and
Western blot analysis with anti-FLAG antibody. Input represents
10% of total. (D) Sedimentation profiles on polysome sucrose
gradients of Stat3, PTEN, IRS1, and PDK1 mRNAs from WT
and CPEBKO liver. The 80S monosome is indicated. RNAs were
quantified by quasi-quantitative RT-PCR. Each experiment was
performed with 3 different animals of each genotype.
(TIF)
Figure S2 CPEB control of IL6 and insulin levels. (A) IL6 levels
in serum from WT and CPEB KO mice on a normal and high fat
diet. The asterisk refers to statistical significance (p,0.05,
Student’s t test). (B) Glucose and insulin levels in WT and CPEB
KO mice when fed normal chow (left panels) or a high fat diet
(right panels). The asterisk refers to statistical significance (p,0.05,
Student’s t test).
(TIF)
Protocol S1 Primers for sequences used in this study.
(DOCX)
Table S1 Identification of sequences from polysomal fractions of
WT and CPEB KO MEFs based on microarray analysis. Extracts
from mouse embryo fibroblasts (MEFs) were centrifuged through
sucrose gradients and the RNA from fractions containing
polysomes was extracted and analyzed by microarrays on an
Affymetrix platform.
(DOC)
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